7Baggers
 InflaRx N.V. (IFRX) Stock Price | Live Quotes & Charts | NASDAQ  StocksToTrade Sat, 15 Nov 2025 00:34:00 GMT
 Is InflaRx NV Gaining or Losing Market Support?  Benzinga Fri, 14 Nov 2025 20:00:46 GMT
 InflaRx earnings missed by €0.03, revenue fell short of estimates  Investing.com Nigeria Fri, 14 Nov 2025 01:21:02 GMT
 InflaRx earnings missed by €0.03, revenue fell short of estimates  Investing.com Thu, 13 Nov 2025 04:37:49 GMT
 inflarx n.v. (ifrx) stock price | live quotes & charts | nasdaq  StocksToTrade Thu, 13 Nov 2025 00:43:00 GMT
 inflarx stock price target raised to $9 from $2 at raymond james on hs drug data  Investing.com Nigeria Wed, 12 Nov 2025 04:06:25 GMT
 InflaRx price target raised to $7 from $3 at Oppenheimer  TipRanks Wed, 12 Nov 2025 02:17:13 GMT
 inflarx reports q3 2025 financial results highlighting operational challenges  The Globe and Mail Tue, 11 Nov 2025 08:00:00 GMT
 InflaRx reports positive Phase 2a data for oral C5aR inhibitor in HS, CSU  Investing.com Nigeria Tue, 11 Nov 2025 06:53:26 GMT
 inflarx n.v. (ifrx) stock price | live quotes & charts | nasdaq  StocksToTrade Tue, 11 Nov 2025 00:44:00 GMT
 InflaRx price target raised to $24 from $3 at Lucid Capital  TipRanks Mon, 10 Nov 2025 21:37:15 GMT
 Guggenheim Maintains InflaRx N.V. (IFRX) Buy Recommendation  Nasdaq Mon, 10 Nov 2025 21:30:00 GMT
 Will the Momentum of InflaRx N.V. Continue?  StocksToTrade Mon, 10 Nov 2025 20:06:00 GMT
 InflaRx price target raised to $22 from $10 at Guggenheim  TipRanks Mon, 10 Nov 2025 16:09:07 GMT
 Why InflaRx N.V. Stock Is Poised For A Rebound?  timothysykes.com Mon, 10 Nov 2025 14:18:00 GMT
 InflaRx reports Phase 2a data for INF904 in HS, CSU  TipRanks Mon, 10 Nov 2025 13:12:12 GMT
 inflarx reports positive phase 2a data for oral c5ar inhibitor in hs, csu by investing.com  Investing.com South Africa Mon, 10 Nov 2025 13:08:02 GMT
 InflaRx stock soars after positive Phase 2a data for INF904 drug  Investing.com Nigeria Mon, 10 Nov 2025 12:52:39 GMT
 inflarx’s anticipated phase 2a results could catalyze stock rally  timothysykes.com Sun, 09 Nov 2025 13:15:00 GMT
 InflaRx Prepares for Key Phase 2a Clinical Trial Results  StocksToTrade Sat, 08 Nov 2025 13:50:00 GMT
 InflaRx to Reveal Phase 2a Clinical Trial Data Amid Q3 2025 Financials  timothysykes.com Sat, 08 Nov 2025 13:20:00 GMT
 inflarx (nasdaq:ifrx) lowered to sell rating by wall street zen  Defense World Sat, 08 Nov 2025 08:03:23 GMT
 InflaRx to report INF904 trial data and Q3 results on Monday  Investing.com Australia Fri, 07 Nov 2025 21:58:31 GMT
 inflarx (ifrx) to release earnings on friday  Defense World Fri, 07 Nov 2025 06:08:26 GMT
 take profit: will inflarx n.v. stock reach all time highs in 2025  fcp.pa.gov.br Tue, 04 Nov 2025 15:35:27 GMT
 perhaps timely catching inflarx n.v (ifrx) would be a good idea  setenews.com Tue, 04 Nov 2025 13:48:00 GMT

InflaRx N.V
(NASDAQ:IFRX) 

IFRX stock logo

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in the Germany and United States. Its C5a is an inflammatory mediator that is involved in the enhancement of a variety of autoimmune and other inflammatory diseases. The company...

Founded: 2018
Full Time Employees: 43
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends